NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

Search Results for Opiate Agonist


Filter Articles: Clinical News | Consumer News | Business News | All News | More Options

Results 1 - 20      Next >


Refine Search
Display Mode: Context | Summary
Data on drug abuse reported by researchers at University of Minnesota, Department of Surgery
2010 FEB 8 ... Medicine, Analgesic, Central Nervous System Disease, Meningitis, Morphine, Narcotic, Opiate Agonist, Pneumococcal, Respiratory Disease, Strep Infection, Streptococcal, Streptococcus, ...
Subject: Drug Abuse
Price: $3.00
*
FDA Approves Morphine Sulfate Oral Solution for Relief of Acute and Chronic Pain
2010 FEB 8 ... overdose. Keywords: Analgesic, Chronic Pain, FDA, Food, Morphine, Narcotic, Opiate Agonist, Regulatory Actions, U.S. Food and Drug Administration. This article was ...
Subject: U.S. Food and Drug Administration
Price: $3.00
*
New methadone therapy research from D.I.G. Cubero and co-researchers described
2010 FEB 8 ... Cancer, Constipation, Drugs, Gastroenterology, Methadone, Morphine, Narcotic, Oncology, Opiate Agonist, Pharmaceuticals, Quality of Life, Therapy, Treatment, Xerostomia. This ...
Subject: Methadone Therapy
Price: $3.00
*
New morphine therapy study findings have been reported from Columbia University
2010 FEB 8 ... States, Morphine Therapy, Analgesia, Analgesic, Columbia University, Morphine, Narcotic, Opiate Agonist, Pain Medicine, Physiology, Psychopharmacology, Therapy, Treatment, Columbia University. ...
Subject: Morphine Therapy
Price: $3.00
*
New morphine therapy study findings reported from Deakin University
2010 FEB 8 ... Morphine Therapy, Analgesic, Antitussive, Codeine, Forensic Science, Morphine, Narcotic, Opiate Agonist, Deakin University. This article was prepared by Biotech Business Week ...
Subject: Morphine Therapy
Price: $3.00
*
New research on fentanyl therapy from University of Minnesota, Department of Pharmacology summarized
2010 FEB 8 ... Kinase, Molecular Pharmacology, Molecular Therapies, Morphine, Narcotic, Neurology, Opiate Agonist, Opioid Receptors, Pharmaceuticals, Pharmacology, Protein Kinase C, Proteins, ...
Subject: Fentanyl Therapy
Price: $3.00
*
Reports summarize opiate receptors study results from University of Washington, Department of Pharmacology
2010 FEB 8 ... 98195 USA. Keywords: City:Seattle, State:Washington, Country:United States, Opiate Receptors, Biological Chemistry, Drugs, Enzymes, GTPase, Kinase, Neurology, Opioid ... "Treatment of AtT-20 cells stably expressing KOR-GFP with the selective KOR agonist U50,488 increased both phospho-p38-ir and pY12-K(ir)3.1-ir. The U50,488-induced increase ...
Subject: Opiate Receptors
Price: $3.00
*
Research from East Tennessee State University, Department of Internal Medicine has provided new information about apoptosis therapy
2010 FEB 8 ... Analgesic, Apoptosis, Biochemical, Biophysics, Internal Medicine, Morphine, Narcotic, Opiate Agonist, Therapy, Treatment. This article was prepared by Biotech Business Week ...
Subject: Apoptosis Therapy
Price: $3.00
*
Research from Shanghai Institute of Materia Medica reveals new findings on morphine therapy
2010 FEB 8 ... China, Morphine Therapy, Analgesic, Drugs, Morphine, Naloxone Hydrochloride, Narcotic, Opiate Agonist, Pharmaceuticals, Pharmacology, Therapy, Treatment. This article was ...
Subject: Morphine Therapy
Price: $3.00
*
Research reports on pharmaceutical and safety from D. Boudreau and colleagues provide new insights
2010 FEB 9 ... Antitussive, Narcotic, Oxycodone Hydrochloride, Pharmaceuticals, Drugs, Morphine, Opiate Agonist, Pain Medicine, Analgesia, Pharmacoepidemiology, Pharmaceutical Research. ...
Subject: Pharmaceutical and Safety
Price: $3.00
*
Researchers from University Cardenal Herrera-CEU publish new studies and findings in the area of buprenorphine therapy
2010 FEB 8 ... the economic impact of buprenorphine/naloxone (B/N) as an agonist opioid treatment for opiate dependence. A budgetary impact analysis model was designed to calculate the annual costs ...
Subject: Buprenorphine Therapy
Price: $3.00
*
Scientists at University of Texas Health Science Center at San Antonio, Health Science Center target dopamine therapy
2010 FEB 8 ... Hydrochloride, Drugs, Experimental Therapies, Hypothermia, Lisuride, Morphine, Narcotic, Opiate Agonist, Pharmaceuticals, Pharmacology, Therapy, Treatment. This article was ...
Subject: Dopamine Therapy
Price: $3.00
*
Studies from Thomas Jefferson University have provided new information about pharmacokinetics
2010 FEB 1 ... Drugs, Epinephrine, Gastroenterology, Lidocaine, Morphine, Morphine Sulfate, Narcotic, Opiate Agonist, Pain Management, Pharmaceuticals, Pharmacokinetics, Pharmacology, Surgery, Therapy, ...
Subject: Pharmacokinetics
Price: $3.00
*
Studies from Washington State University describe new findings in morphine therapy
2010 FEB 1 ... Drugs, Fentanyl Citrate, Morphine, Morphine Therapy, Narcotic, Neurology, Opiate Agonist, Opioid Receptors, Pain Medicine, Pharmaceuticals, Therapy, Treatment This ...
Subject: Morphine Therapy
Price: $3.00
*
Studies from Z. Dong and colleagues yield new information about morphine therapy
2010 FEB 8 ... Analgesic, Drugs, Mental Health, Morphine, Naloxone Hydrochloride, Narcotic, Neurology, Opiate Agonist, Opioid Receptors, Pharmaceuticals, Psychology, Therapy, Treatment. This ...
Subject: Morphine Therapy
Price: $3.00
*
Studies in the area of pruritus therapy reported from University Hospital
2010 FEB 1 ... Drugs, Fentanyl Citrate, Granisetron, Morphine, Narcotic, Obstetrics, Ondansetron, Opiate Agonist, Pain Medicine, Pharmaceuticals, Pruritus, Serotonin Antagonist, Therapy, Treatment, ...
Subject: Pruritus Therapy
Price: $3.00
*
Studies in the area of remifentanil therapy reported from M.R. Douma and co-researchers
2010 FEB 1 ... Drugs, Fentanyl Citrate, Hypnotics and Sedatives, Meperidine, Narcotic, Neurology, Opiate Agonist, Pain Medicine, Pharmaceuticals, Remifentanil, Stem Cell Research, Therapy, Transfusion ...
Subject: Remifentanil Therapy
Price: $3.00
*
Study data from T.L. Holbrook and co-authors update knowledge of traumatic stress disorders
2010 FEB 8 ... Country:United States, Analgesic, Brain Injuries, Mental Health, Morphine, Narcotic, Opiate Agonist, PTSD, Pharmaceuticals, Pharmacotherapy, Post Traumatic Stress Disorder, Post-Traumatic ...
Subject: Traumatic Stress Disorders
Price: $3.00
*
Study findings from Health Research Institute provide new insights into life sciences
2010 FEB 1 ... HMO, Chronic Pain, Clinical Trial Research, Morphine, Analgesic, Narcotic, Opiate Agonist, Treatment, Therapy, Diagnostics, Internal Medicine, Pharmaceuticals. This ...
Subject: Life Sciences
Price: $3.00
*
Study findings on morphine therapy are outlined in reports from University of Minnesota, Department of Pharmacology
2010 FEB 8 ... Therapy, Analgesic, Bloodstream Infection, Chronic Pain, Drugs, Morphine, Narcotic, Opiate Agonist, Pathology, Pharmaceuticals, Pharmacology, Sepsis, Septicemia, Therapy, Treatment. ...
Subject: Morphine Therapy
Price: $3.00
*

Results 1 - 20      Next >




-----------------------
PR Login